• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Decreased unnecessary urine cultures associated with decreased asymptomatic bacteriuria-related antibiotic use

byYasin AvciandYuchen Dai
August 13, 2023
in Infectious Disease, Urology
Reading Time: 3 mins read
Of Background Image
Share on FacebookShare on Twitter

1. This quality improvement study’s results suggested that more selective urine testing was conducted in 3 years as the percentage of patients with a positive urine culture with asymptomatic bacteriuria (ASB) (diagnostic stewardship metric) declined from 34.1% to 22.5%.

2. The percentage of patients with ASB who received antibiotics (antibiotic stewardship metric) and antibiotic duration for ASB did not significantly change (82.0% to 76.3% and 6.38 to 5.93 days).

Evidence Rating Level: 2 (Good)

Study Rundown: It is very common for hospitalized patients to experience ASB. Treatment of ASB with antibiotics often does not improve outcomes but rather exposes patients to antibiotic-associated harm, including adverse drug events and resistance, potentially prolonging hospital stays. With this said, antibiotic overuse is still prevalent, so this quality improvement study sought to determine whether stewardship focused on diagnostic testing or antibiotic treatment is associated with reduced ASB treatment in hospitalized patients. It was found that diagnostic stewardship (reducing unnecessary urine cultures) was associated with decreased ASB-related antibiotic use, while antibiotic stewardship (reducing unnecessary antibiotic use in asymptomatic patients found to have a positive urine culture) did not reveal significant associations. One study limitation is the absence of data on hospitalized patients who didn’t undergo urine cultures, making it uncertain if they received antibiotic therapy. In conclusion, these findings suggest hospitals should prioritize diagnostic stewardship to decrease ASB-related antibiotic treatment.

Click to read the study in JAMA Internal Medicine

Click to read an accompanying editorial in JAMA Internal Medicine

RELATED REPORTS

Antibiotic prescribing remains high for uncomplicated diverticulitis 

Poor glycemic control may not be associated with increased outpatient antibiotic prescription rates

Point of care C-reactive protein testing may be useful in guiding antibiotic prescribing

Relevant Reading: Risk Factors and Outcomes Associated With Treatment of Asymptomatic Bacteriuria in Hospitalized Patients

In-Depth [prospective cohort]: This study was a 3-year (from July 2017 to March 2020), 46-hospital quality improvement study including 14572 patients with positive urine cultures. This study was a part of the Michigan Hospital Medicine Safety Consortium (HMS), a statewide collaborative quality initiative to measure and improve the quality of existing care practices through three main pillars: data with benchmarking, sharing of best practices, and pay-for-performance data. Patients were qualified for inclusion if they were admitted to an HMS hospital, had a positive urine culture, and did not receive antibiotics for another infection during their hospital stay. Patients were categorized as having ASB if they showed no signs or documented symptoms of a urinary tract infection (UTI) according to national guidelines. The primary outcomes were the overall ASB-related antibiotic use metric (ASB treated with antibiotics / (UTI treated with antibiotics + ASB treated with antibiotics)), diagnostic stewardship metric (ASB (ie, treated + untreated) / Positive urine culture (ie, UTI + ASB)), and antibiotic stewardship metric (ASB treated with antibiotics / ASB (ie, treated + untreated)).

Overall ASB-related antibiotic use decreased over the study period from 29.1% (95% CI, 26.2%-32.2%) to 17.1% (95% CI, 14.3%-20.2%). With regards to diagnostic stewardship, there was a decline in the percentage of patients with a positive urine culture who had ASB from 34.1% (95% CI, 31.0%-37.3%) to 22.5% (95%CI, 19.7%-25.6%). With regards to the antibiotic stewardship metric, the percentage of patients with ASB who received antibiotics did not significantly differ from 82.0% (95% CI, 77.7%-85.6%) to 76.3% (95% CI, 68.5%-82.6%). The antibiotic duration for ASB also did not significantly change (6.38 days (95% CI, 6.00-6.78 days) to 5.93 days (95% CI, 5.54-6.35 days)).

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibiotic stewardshipAsymptomatic bacteriuriadiagnostic stewardship
Previous Post

#VisualAbstract: Dolutegravir noninferior to a ritonavir-boosted protease inhibitor regimen for treating HIV

Next Post

Ticagrelor-acetylsalicylic acid may reduce stroke risk further for obese patients than clopidogrel

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Gastroenterology

Antibiotic prescribing remains high for uncomplicated diverticulitis 

June 22, 2026
Endocrinology

Poor glycemic control may not be associated with increased outpatient antibiotic prescription rates

December 16, 2024
2 Minute Medicine Rewind May 20, 2019
Emergency

Point of care C-reactive protein testing may be useful in guiding antibiotic prescribing

December 6, 2024
Prescription of antibiotics for acute respiratory infections increasing
Emergency

Biomarkers may help guide antibiotic stewardship in community acquired pneumonia

August 26, 2024
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Ticagrelor-acetylsalicylic acid may reduce stroke risk further for obese patients than clopidogrel

#VisualAbstract: Hemodynamic monitoring improves quality of life and reduces hospitalizations in heart failure patients

#VisualAbstract: Hemodynamic monitoring improves quality of life and reduces hospitalizations in heart failure patients

Provision of medically-tailored meals linked with lower admissions and medical spending

Positioning food and restaurant options in order of ascending energy content promotes lower-energy meal choices

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.